ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2022

Abstract Number: 2068

All-Cause Mortality in a Systemic Lupus Erythematosus Cohort

Michelle Petri1, Joseph Levy2, Urbano Sbarigia3 and Daniel W. Goldman1, 1Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, MD, 2Bloomberg School of Public Health, Baltimore, MD, 3Johnson & Johnson, Beerse, Belgium

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2022

Keywords: Mortality, Systemic lupus erythematosus (SLE)

Session Information

Date: Monday, November 14, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Multiple studies have documented that patients with SLE have a higher all-cause mortality. Active disease contributes to early deaths with later deaths more likely due to cardiovascular disease and malignancy. In this study we present the pattern of mortality in a single long-term, prospective cohort using death certificates to document cause of death.

Methods: The cohort consists of 2,238 patients (92% female, 52% Caucasian, 39% African-American) with 92% from Maryland and surrounding states (MD 71%, VA 9%, PA 7%, DE 3%, WV 1%, DC 1%). Death records for 1,288 patients lost to follow up prior to 2020 were obtained from the National Death Index (NDI) at the Center for Disease Control (Atlanta, GA). The NDI identified 11,369 death records from 1985 to 2019 as possible matches based on name, gender, race, and date of birth. Primary and secondary causes of death were provided for the best match for each patient. The causes of death were based on CDC classifications of ICD10 and ICD9 codes. Lupus was identified as a cause of death if ICD10 code M32.X or L93.0, or ICD9 code 695.X or 710.0 was listed on the death record.

There were 207 death records identified by matching the NDI data elements and the date of death on the certificate to the date of death reported by the family. Analysis of these 207 records provided the following set of criteria that identified additional death records from the remaining 1,079 patients lost to follow up: 1) date of death occurred after the patient was lost to follow up; 2) at least six out of seven data elements sent to NDI matched those on the death record; and 3) EITHER lupus was listed as a cause of death on the death record OR the state of residence matched the state listed on the death record. Using these criteria, an additional 297 death records were found (Table 1).

Results: The leading primary causes of death listed on the death certificate were: lupus (n=116, 23%), cardiovascular (n=114, 23%), cancer (n=74, 15%), infection (n=66, 13%), other (n=55, 11%), respiratory (n=28, 6%), accidental (n=17, 3%), renal (n=9, 2%) and gastrointestinal (n=8, 2%). Lupus deaths and accidental deaths occurred at a significantly younger age (p-values less than 0.05 for paired t-tests; Figure 1). African-Americans died at a younger age compared to Caucasians (50 ± 15 years vs 58 ± 16 years, p< 0.001). African-Americans had a higher proportion of deaths from infections and renal causes compared to Caucasians (p=0.0017 Likelihood ratio test; Figure 2).

Conclusion: SLE patients died at an average of 55 years of age for all causes of death (compared to life expectancies of >80 years for females in the US), with lupus and cardiovascular disease identified as the leading causes of death on death certificates. Cancer and infection were the third and fourth causes of death. African-Americans died younger than Caucasians and had more infection and renal causes of death. Only respiratory deaths were significantly more common in Caucasians.

Supporting image 1

Table 1 – Matching Criteria for Death Records

Supporting image 2

Figure 1 – Age at Death versus Cause of Death

Supporting image 3

Figure 2: Cause of Death for Caucasians versus African-Americans


Disclosures: M. Petri, Exagen, AstraZeneca, Alexion, Amgen, AnaptysBio, Argenx, Aurinia, Biogen, Caribou Biosciences, CVS Health, EMD Serono, Eli Lilly, Emergent Biosolutions, GlaxoSmithKline (GSK), IQVIA, Janssen, Kira Pharmaceuticals, MedShr, Sanofi, SinoMab, Thermofisher, BPR Scientific Advisory Committee; J. Levy, Janssen; U. Sbarigia, Janssen; D. Goldman, None.

To cite this abstract in AMA style:

Petri M, Levy J, Sbarigia U, Goldman D. All-Cause Mortality in a Systemic Lupus Erythematosus Cohort [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/all-cause-mortality-in-a-systemic-lupus-erythematosus-cohort/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/all-cause-mortality-in-a-systemic-lupus-erythematosus-cohort/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology